B Vitamins May Cut Fracture Risk After Stroke
Taking folate and
vitamin B12 supplements after suffering a stroke can reduce the risk of hip
fractures, a new study reports.
The risk of hip fracture is two to four times higher than normal after a stroke.
But the study found almost a five-fold reduction in the risk of a hip fracture
due to supplement use following a stroke, the researchers said.
"Stroke patients should routinely intake these vitamins to avoid hip fractures,
because hip fractures are associated with more deaths, disabilities and medical
costs than all other osteoporosis-related fractures combined," said study author
Dr. Yoshihiro Sato, a professor at Hirosaki University School of Medicine in
Japan.
Sato said these vitamins might reduce fracture risk by lowering homocysteine
levels. High levels of homocysteine -- a naturally occurring amino acid -- are a
risk factor for both stroke and bone fractures. Sato said homocysteine may
interfere with the microarchitecture of the bone.
The finding appears in the March 2 issue of the Journal of the American Medical
Association.
Joyce van Meurs, co-author of an accompanying editorial in the journal, said
lowering homocysteine levels could have either a direct or indirect effect on
bone. Directly, homocysteine may interfere with collagen cross-linking, a
process she said is crucial for strong bones. So, lowering levels of
homocysteine could lead to stronger bones.
Indirectly, high homocysteine levels are associated with other diseases, such as
cardiovascular disease and dementia that may increase the risk of a fall or
fracture, according to van Meurs. But, she said, the Japanese researchers
accounted for these factors, so they're not likely the reason for the reduced
risk seen in this study.
For the study, the researchers followed 559 Japanese stroke patients, aged 65 or
over, for two years. All of the study volunteers had had a stroke at least one
year before the start of the study, and none was taking any medication that
affected bone metabolism.
The study volunteers were randomly split into two groups. Half were given 5
milligrams of folate, a water-soluble B vitamin, and 1,500 micrograms of vitamin
B12 daily for two years, while the other half received two placebo pills daily.
At the end of two years, homocysteine levels in the group that received the
vitamin combination were reduced by 38 percent.
Six people in the treated group suffered hip fractures during the study period
compared to 27 in the placebo group -- a nearly five-fold difference.
"In this Japanese population with a high baseline fracture risk, combined
treatment with folate and vitamin B12 is safe and effective in reducing the risk
of a hip fracture in elderly stroke patients," Sato said.
Because the vitamins were used in combination, van Meurs said it's not possible
to know from this study whether one supplement was more important in reducing
the risk of fracture.
"The study shows a clear difference in fracture incidence between patients that
receive folate/[B12] treatment and placebo," said van Meurs.
However, she added, "More and larger studies are needed in order to give a
conclusive answer whether and to what extent these supplements prevent
fractures. If these results hold, this would add an effective, safe and cheap
treatment for fracture prevention without adverse side effects. Meanwhile, since
these supplements are thought to be beneficial without any adverse effects, I
would suggest giving them to patients."
Sato strongly agreed that stroke patients should be given these supplements to
help prevent fractures.
health day news